CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical Outcomes after Switching from As-needed to Proactive Injections in the Neovascular Age-related Macular Degeneration
Soo Hyun Lim, Jae Hyung Hwang, Jong Woo Kim, Chul Gu Kim, Dong Won Lee, Jae Hui Kim
J Korean Ophthalmol Soc. 2020;61(6):630-638.   Published online June 15, 2020
DOI: https://doi.org/10.3341/jkos.2020.61.6.630

Excel Download

Clinical Outcomes after Switching from As-needed to Proactive Injections in the Neovascular Age-related Macular Degeneration
Journal of the Korean Ophthalmological Society. 2020;61(6):630-638   Crossref logo
Link1 Link2 Link3

No functional vision improvement after intravitreal ranibizumab injections (IVT) for retrofoveolarchoroidal neovascular age-related macular degeneration, why?
Acta Ophthalmologica. 2008;86:0-0   Crossref logo
Link1 Link2

Pathogenesis of neovascular age-related macular degeneration
Age-Related Macular Degeneration. 2022;165-183   Crossref logo
Link1 Link2

Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab
Clinical Ophthalmology. 2017;Volume 11:715-721   Crossref logo
Link1 Link2

Analysis of intravitreal ranibizumab injections effects on exudative reaction complicating subfoveal choroidal neovascular age related macular degeneration (AMD)
Acta Ophthalmologica. 2008;86:0-0   Crossref logo
Link1 Link2

The Neovascular Age-Related Macular Degeneration Database: Multicenter Study of 92 976 Ranibizumab Injections
Ophthalmology. 2014;121(5):1092-1101   Crossref logo
Link1 Link2

Radiation therapy for neovascular age-related macular degeneration
Clinical Ophthalmology. 2011;57   Crossref logo
Link1

Clinical characteristics and outcomes after 5 yearspro re natatreatment of neovascular age-related macular degeneration with ranibizumab
Acta Ophthalmologica. 2014;93(6):e511-e512   Crossref logo
Link1

Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761)
Ophthalmology. 2017;124(3):e31-e32   Crossref logo
Link1 Link2

Assessment of retinal vessel caliber changes in eyes with non-neovascular age-related macular degeneration after progression to neovascular age-related macular degeneration
Graefe's Archive for Clinical and Experimental Ophthalmology. 2015;254(3):599-601   Crossref logo
Link1 Link2 Link3